PTCT: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Cash Flow Overview

No enough data to generate the overview

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Total revenues	1,565,978	-
Cost of product, collaboration and license sales	28,241	-
Program spend	143,803	-
Employee costs	197,762	-
Manufacturing costs	45,517	-
Administrative costs	54,924	-
Occupancy costs	21,678	-
Total other segment items	256,444	-
Net income (loss) attributable to common stockholders	817,609	801,713
Depreciation and amortization	25,913	14,804
Non-cash operating lease expense	5,635	3,634
Non-cash royalty revenue related to sale of future royalties	149,160	85,099
Non-cash interest expense on liability related to sale of future royalties	149,305	99,329
Tangible asset impairment	-	100
Change in valuation of contingent consideration	-800	-800
Loss on sale of fixed assets	-	-77
Tangible asset impairment	518	99
Loss on sale of fixed assets	-130	-100
Unrealized gain on clearpoint equity investments	5,734	-3,078
Unrealized gain on marketable securities - equity investments	3,160	1,538
Disposal of asset	-163	-
Deferred income taxes	-4	-
Amortization of discounts on investments, net	12,972	6,869
Amortization of debt issuance costs	906	601
Share-based compensation expense	56,029	36,603
Unrealized foreign currency transaction losses (gains), net	-4,768	-4,939
Inventory, net	27,117	8,591
Prepaid expenses and other current assets	13,876	12,197
Trade and royalty receivables, net	32,365	25,891
Deposits and other assets	-1,501	827
Accounts payable and accrued expenses	-36,341	6,864
Other liabilities	-26,497	-17,320
Deferred revenue	-4,298	3,845
Payments on contingent consideration	-4,684	-4,684
Net cash provided by (used in) operating activities	745,469	811,770
Purchases of fixed assets	6,486	3,041
Proceeds from sale of fixed assets	70	70
Purchases of marketable securities- available for sale	1,051,267	847,164
Purchases of marketable securities- equity investments	46,537	17,029
Sale and redemption of marketable securities- available for sale	424,351	247,151
Sale and redemption of marketable securities- equity investments	40,112	17,129
Acquisition of product rights and licenses	256,235	3,485
Net cash used in investing activities	-895,992	-606,369
Proceeds from exercise of options	33,715	16,885
Proceeds from employee stock purchase plan	2,827	2,827
Payments on contingent consideration obligation	6,341	6,341
Payment of finance lease principal	1,611	-
Net cash provided by financing activities	28,590	13,371
Effect of exchange rate changes on cash	12,917	18,981
Net decrease in cash and cash equivalents	-109,016	237,753
Cash and cash equivalents at beginning of period	795,316	-
Cash and cash equivalents at end of period	686,300	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

PTCT: the cashflow